Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the ability of Aquacel® Ag and Mepilex® Border Ag to manage bioburden in leg ulcers over a two week study period.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01427491
Study type Interventional
Source ConvaTec Inc.
Contact
Status Completed
Phase Phase 3
Start date August 2011
Completion date January 2012

See also
  Status Clinical Trial Phase
Terminated NCT00762138 - The AutoloGelâ„¢ Post-Market Surveillance (TAPS) Program N/A
Recruiting NCT02583958 - Assessment of Efficacy & Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers N/A
Completed NCT00007280 - Bioengineered Skin and Wound Healing Phase 1
Completed NCT01238419 - Physiotulle vs Urgotul in the Treatment of Leg Ulcer Phase 4
Active, not recruiting NCT05561140 - Resolution of Sickle Cell Leg Ulcers With Voxelotor Phase 3
Completed NCT00710489 - Potential Research Study Participant Registry
Completed NCT00628004 - Safety Evaluation of Biatain Ibu in Painful Chronic Venous Leg Ulcers N/A
Completed NCT00821431 - Compression Device Versus 4-layer Compression System Phase 2
Not yet recruiting NCT00922389 - A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia Phase 1/Phase 2
Completed NCT00184873 - Legtest Multi Centre Testing of the Lively Legs Program for Promoting Compliance in Leg Ulcer Patients N/A
Completed NCT00807664 - Biatain Ag vs Biatain in the Treament of Leg Ulcers N/A
Completed NCT00522002 - CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study N/A
Completed NCT02632695 - Physical Activity Interventions for Leg Ulcer Patients N/A